Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trial.
Saved in:
| Title: | Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): phase II randomized clinical trial. |
|---|---|
| Authors: | Colmegna I; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; The Research Institute of the McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Department of Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: ines.colmegna.med@ssss.gouv.qc.ca., Hudson M; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Biard L; INSERM U1342, Team ECSTRRA, Hôpital Saint Louis, Paris, France; AP-HP Hôpital Saint Louis, Service de Biostatistique et Information Médicale, Paris, France., Azuelos I; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Respiratory Division, Department of Medicine, McGill University, Montreal, Quebec, Canada., Davies L; NextCell Pharma AB, Huddinge, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden., Hirsch A; Respiratory Division, Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Center of Excellence in Thrombosis and Anticoagulation Care (CETAC), Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Leger S; Division of Rheumatology, Department of Medicine, McGill University, Montreal, Quebec, Canada., McDonald EG; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Department of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada; Centre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada., Peltier L; Cellular Therapy Laboratory, McGill University Health Centre (MUHC), McGill University, Montreal, Quebec, Canada., Popradi G; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Division of Hematology, Department of Medicine, McGill University, Montreal, Quebec, Canada., Resche-Rigon M; AP-HP, Department of Biostatistics and Medical Information, Saint-Louis Hospital, Paris, France; INSERM, UMR-1153, ECSTRRA Team, Paris, France., Robitaille C; Respiratory Division, Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Svahn M; NextCell Pharma AB, Huddinge, Sweden., Walter-Petrich A; AP-HP Hôpital Saint Louis, Service de Biostatistique et Information Médicale, Paris, France., Martin JG; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; Respiratory Division, Department of Medicine, McGill University, Montreal, Quebec, Canada., Farge-Bancel D; Division of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada; INSERM U1342, Team ECSTRRA, Hôpital Saint Louis, Paris, France; Internal Médicine Unit (04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France, AP-HP, Hôpital Saint-Louis, Université Paris Cité, Paris, France. |
| Source: | Cytotherapy [Cytotherapy] 2026 Jul; Vol. 28 (7), pp. 102775. Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
